PTRN vs VRTX · rev $2.50B vs P/E 30, rev $12.00B
Pattern Group Inc. Series A Common Stock (PTRN) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Pattern Group Inc. Series A Common Stock (PTRN) is a software - application company listed on NASDAQ.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported PTRN revenue for 2025-12-31 was $2.50B. Net income was $16.2M. Revenue was up 39.3% from 2024-12-31 to 2025-12-31. PTRN currently screens at market cap $3.68B.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
PTRN currently screens at market cap $3.68B. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the PTRN and VRTX stock pages for the full models.
Not investment advice.